AbbVie Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
ABBV on NYSE
Location
North Chicago, IL
Fiscal year end
31 December
Latest financial report
20 Feb 2026

Quick Takeaways

  • ABBV - AbbVie Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Invested Capital 18%.

What Changed

  • Return On Invested Capital YoY change: <span class="text-green-600">+24%</span>.
  • Most recent SEC facts end date: 10 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-10) highlights Return On Invested Capital 17.8%, Return On Equity 6225.0%, and Return On Assets 9.8%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

68.1/100

Balanced Confidence high

Return On Invested Capital

18%

Metric score 85.4/100

Return On Equity

6225%

Metric score 100.0/100

Return On Assets

9.8%

Metric score 97.6/100

Financial Health

Current Ratio
0.67x
Quick Ratio
0.41x
Debt to Equity
-18.02x

Strengths

Return On Invested Capital, Return On Equity, and Return On Assets

Watchpoints

Debt-to-equity and NetIncomeLoss YoY

Key metrics snapshot

Return On Equity

6225%

YoY: +24479%

Industry median: -43% (n=671)

View history

Return On Assets

9.8%

YoY: -0.94%

Industry median: -48% (n=669)

View history

Operating Margin

34%

YoY: +52%

Industry median: -128% (n=298)

View history

Current Ratio

0.67x

YoY: +1.7%

Industry median: 3.39x (n=667)

View history

Quick Ratio

0.41x

YoY: -3%

Industry median: 2.02x (n=287)

View history

Debt-to-equity

-18.02x

YoY: -199%

Industry median: 0.28x (n=634)

View history

Revenues YoY

8.6%

YoY:

Industry median: 5% (n=103)

View history

NetIncomeLoss YoY

-1.2%

YoY:

Industry median: -0.54% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Invested Capital 18% +24%
Return On Equity 6225% +24479%
Return On Assets 9.8% -0.94%
Operating Margin 34% +52%

Financial Health

Metric Latest value YoY change
Current Ratio 0.67x +1.7%
Quick Ratio 0.41x -3%
Debt-to-equity -18.02x -199%

Growth

Metric Latest value YoY change
Revenues YoY 8.6%
NetIncomeLoss YoY -1.2%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 1,768,169,012 +0.16%
Weighted Average Number of Shares Outstanding, Basic 1,769,000,000 0%
Weighted Average Number of Shares Outstanding, Diluted 1,773,000,000 0%

Additional Metrics

Metric Latest value YoY change
Costs and Expenses $46,085,000,000 -2.4%
Operating Income (Loss) $15,075,000,000 +65%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $6,597,000,000 +78%
Income Tax Expense (Benefit) $2,364,000,000
Earnings Per Share, Basic 2.36 -1.7%
Earnings Per Share, Diluted 2.36 -1.7%
Cash and Cash Equivalents, at Carrying Value $5,229,000,000 -5.3%
Accounts Receivable, after Allowance for Credit Loss, Current $12,589,000,000 +15%
Inventory, Net $4,951,000,000 +18%
Assets, Current $29,062,000,000 +14%
Property, Plant and Equipment, Net $5,628,000,000 +9.6%
Operating Lease, Right-of-Use Asset $737,000,000 +1.9%
Intangible Assets, Net (Excluding Goodwill) $52,641,000,000 -12%
Goodwill $35,640,000,000 +2%
Other Assets, Noncurrent $10,721,000,000 +17%
Assets $133,960,000,000 -0.89%
Accounts Payable, Current $3,592,000,000 +22%
Employee-related Liabilities, Current $2,219,000,000 +12%
Liabilities, Current $43,289,000,000 +12%
Long-term Debt and Lease Obligation $58,941,000,000 -2.3%
Accrued Income Taxes, Noncurrent $364,000,000 -71%
Deferred Income Tax Liabilities, Net $2,389,000,000 -7.4%
Operating Lease, Liability, Noncurrent $689,000,000 -1.1%
Other Liabilities, Noncurrent $32,569,000,000 +8.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,144,000,000 +41%
Retained Earnings (Accumulated Deficit) $15,493,000,000 -96%
Stockholders' Equity Attributable to Parent $3,270,000,000 -198%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,228,000,000 -196%
Liabilities and Equity $133,960,000,000 -0.89%
Common Stock, Shares Authorized 4,000,000,000 0%
Common Stock, Shares, Issued 1,838,678,628 +0.39%
Common Stock, Par or Stated Value Per Share 0.01 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,229,000,000 -5.3%
Deferred Tax Assets, Valuation Allowance $15,018,000,000 +1.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 0%
Deferred Tax Assets, Gross $21,215,000,000 +1.7%
Operating Lease, Liability $883,000,000 +0.91%
Depreciation $762,000,000 -0.26%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,007,000,000 +7.5%
Lessee, Operating Lease, Liability, to be Paid $985,000,000 +1.1%
Property, Plant and Equipment, Gross $13,530,000,000 +10%
Operating Lease, Liability, Current $194,000,000 +9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $187,000,000 +2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.035 +6.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $102,000,000 +3%
Lessee, Operating Lease, Liability, to be Paid, Year Three $157,000,000 +8.3%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 200,000,000 0%
Unrecognized Tax Benefits $4,505,000,000 +2.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four $133,000,000 +13%
Amortization of Intangible Assets $7,377,000,000 -3.2%
Deferred Tax Assets, Net of Valuation Allowance $6,197,000,000 +2.7%
Share-based Payment Arrangement, Expense $955,000,000 +4.8%
Interest Expense $2,893,000,000 +3%
Preferred Stock, Par or Stated Value Per Share 0.01 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY